Zhixiang Cheng

1.4k total citations
31 papers, 1.1k citations indexed

About

Zhixiang Cheng is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Zhixiang Cheng has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Zhixiang Cheng's work include Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zhixiang Cheng is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zhixiang Cheng collaborates with scholars based in China, United States and South Korea. Zhixiang Cheng's co-authors include Zhaoxia Wang, Jialiang Wang, Yufang Ma, Yuanying Gong, Reid C. Thompson, He Wang, Yongmei Yin, Binbin Lu, Kaihua Lu and Stefan Knapp and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.

In The Last Decade

Zhixiang Cheng

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by Zhixiang Cheng

Since Specialization

Citations

This map shows the geographic impact of Zhixiang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiang Cheng more than expected).

Fields of papers citing papers by Zhixiang Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiang Cheng. The network helps show where Zhixiang Cheng may publish in the future.

Co-authorship network of co-authors of Zhixiang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiang Cheng. A scholar is included among the top collaborators of Zhixiang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiang Cheng. Zhixiang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Dynamics-Powered Hierarchical Geometric Deep Learning Framework for Protein-Ligand Interaction 2025 ·PubMed ·Mingquan Liu, Shuting Jin, (unknown), Longyue Wang, Jianmin Wang, Zhixiang Cheng, Xiangzheng Fu	0
2	Deciphering the profiles and hosts of antibiotic resistance genes and evaluating the risk assessment of general and non-general hospital wastewater by metagenomic sequencing 2025 ·Environmental Pollution ·Yue Gao, Zhixiang Cheng, (unknown), (unknown), Jie Hu, Shunli Wang, Zhi Wang, Mingchao Wang, Shenghai Huang, Maozhen Han	0
3	LncRNA PVT1 activated by TGF-β1/Smad3 facilitates proliferation and metastasis of hepatocellular carcinoma via upregulating Smad6 and NRG1 2025 ·Journal of Translational Medicine ·Shengyu Wu, Qian Cheng, Yang Shi, Kunlei Wang, Zhi‐Nan Chen, (unknown), Ping Jiang, Zhixiang Cheng, (unknown), (unknown)	1
4	Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease 2025 ·EMBO Molecular Medicine ·Hongze Chen, Muhammad Azhar Nisar, (unknown), Xinjian Li, (unknown), Shaolei Lu, Katsuya Nagaoka, (unknown), Peng–Sheng Ting, Tung‐Sung Tseng, Hui‐Yi Lin, Xiao-Ming Yin, Wenke Feng, Zhijin Wu, Zhixiang Cheng, William F. Mueller, (unknown), (unknown), Xuewei Bai, Chiung‐Kuei Huang	1
5	Targeting BET proteins inhibited the growth of non‐small cell lung carcinoma through downregulation of Met expression 2022 ·Cell Biology International ·Ting Yuan, Ping Ni, Zuhao Zhang, Dandan Wu, Geng Sun, Haijun Zhang, Baoan Chen, Xuerong Wang, Zhixiang Cheng	2
6	Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways 2022 ·International Journal of Biological Sciences ·(unknown), Hao Zhang, (unknown), Zhixiang Cheng, Ping Jiang, Maohui Feng, Bo Liao, Zhisu Liu	20
7	The Potential of Gut Microbiota Metabolic Capability to Detect Drug Response in Rheumatoid Arthritis Patients 2022 ·Frontiers in Microbiology ·Maozhen Han, Na Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Long Chen, Yan Liu, Shanshan Wang, Shenghai Huang, Zhixiang Cheng	7
8	The role of RNA N6-methyladenosine methyltransferase in cancers 2020 ·Molecular Therapy — Nucleic Acids ·Jiali Huang, Zhenyao Chen, Xin Chen, Jun Chen, Zhixiang Cheng, Zhaoxia Wang	24
9	A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation 2020 ·Frontiers in Pharmacology ·Hao Chen, Yuanying Gong, Yufang Ma, Reid C. Thompson, Jialiang Wang, Zhixiang Cheng, (unknown)	17
10	Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1 2020 ·Cell Death and Disease ·Zhenyao Chen, Qinnan Chen, Zhixiang Cheng, Jingyao Gu, (unknown), Tianyao Lei, Jiali Huang, (unknown), Xin Chen, Zhaoxia Wang	87
11	High mobility group box‐1‐toll‐like receptor 4‐phosphatidylinositol 3‐kinase/protein kinase B‐mediated generation of matrix metalloproteinase‐9 in the dorsal root ganglion promotes chemotherapy‐induced peripheral neuropathy 2019 ·International Journal of Cancer ·(unknown), Chaoyu Wang, Jiajie Li, Yang Yang, Wenyue Sun, Chun‐Yi Jiang, Yan Li, Ming Ni, Wentao Liu, Zhixiang Cheng, Liang Hu	34
12	Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells 2017 ·Stem Cell Reports ·Yufang Ma, Zhixiang Cheng, (unknown), Luke A. Torre-Healy, Justin D. Lathia, Ichiro Nakano, Yan Guo, Reid C. Thompson, Michael L. Freeman, Jialiang Wang	22
13	Critical functions of RhoB in support of glioblastoma tumorigenesis 2014 ·Neuro-Oncology ·Yufang Ma, Yuanying Gong, Zhixiang Cheng, Sudan N. Loganathan, (unknown), Jann N. Sarkaria, Ty W. Abel, Jialiang Wang	27
14	Serum neutrophil gelatinase-associated lipocalin and proinflammatory cytokines in pigs with septic versus non-septic acute kidney injury 2014 ·International Urology and Nephrology ·(unknown), Miao Zhang, Huijuan Mao, Zhixiang Cheng, Qingyan Zhang, Chunming Jiang, Chen Sun, Lingyun Sun	9
15	Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma 2013 ·Clinical Cancer Research ·Zhixiang Cheng, Yuanying Gong, Yufang Ma, Kaihua Lu, Xiang Lu, Larry A. Pierce, Reid C. Thompson, Susanne Müller, Stefan Knapp, Jialiang Wang	233
16	Abstract 1018: Inhibition of BET bromodomain targets genetically diverse glioblastoma. 2013 ·Cancer Research ·Jialiang Wang, Zhixiang Cheng	3
17	Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer 2012 ·Carcinogenesis ·Jingsong Chen, Xiaohui Huang, Qian Wang, Jiongqiang Huang, Longjuan Zhang, Xilin Chen, Jian Lei, Zhixiang Cheng	141
18	MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN 2011 ·Archives of Medical Research ·Zhaoxia Wang, Binbin Lu, He Wang, Zhixiang Cheng, Yongmei Yin	134
19	Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells 2010 ·Phytomedicine ·Zhixiang Cheng, Keming Wang, Jia Wei, Xiang Lü, Baorui Liu	13
20	Proteomic analysis of anti-tumor effects by Rhizoma Paridis total saponin treatment in HepG2 cells 2008 ·Journal of Ethnopharmacology ·Zhixiang Cheng, Baorui Liu, Xiaoping Qian, Yitao Ding, Wenjing Hu, Jing Sun, Lixia Yu	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact